Tmunity Therapeutics

31 articles with Tmunity Therapeutics

• Tmunity to Present at the 2020 RBC Capital Markets Healthcare Private Company Conference

  12/9/2020

  Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today announced that President & CEO Usman “Oz” Azam will participate in a Fireside Chat at the 2020 RBC Capital Markets Healthcare Private Company Conference on Tuesday, December 15, 2020 at 11:20 am Eastern Time. To access a liv

• Tmunity to Present at Upcoming Investor Conferences - Nov 05, 2020

  11/5/2020

  Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, announced that President & CEO Usman “Oz” Azam will present at two upcoming virtual investor conferences in November.​

• Tmunity to Present at Upcoming Investor Conferences - Sep 29, 2020

  9/29/2020

  Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, announced that President & CEO Usman “Oz” Azam is scheduled to present at two upcoming virtual investor conferences.​

• Tmunity Announces Additional Senior Leadership Appointments

  9/8/2020

  Dr. Vijay Reddy and Simona King, CPA, MBA to Join Executive Team as Chief Research and Development Officer and Chief Financial Officer.

• Tmunity to Present at Upcoming Investor Conferences

  2/19/2020

  Feb. 19, 2020 12:00 UTC PHILADELPHIA--( BUSINESS WIRE )-- Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today announced that management is scheduled to present at two upcoming investor conferences. Cowen 40th Annual Health Care Conference Monday, March 2, 2020 1:30 PM ET Boston, MA Oppenheimer 30th Annual Healthcare Conferen

• Tmunity Announces First Patient Dosed in Phase 1 Clinical Trial with CART-TnMUC1

  1/15/2020

  Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today announced that it has dosed the first patient in its Phase 1 CART-TnMUC1-01 clinical trial with the Tn/STn glycoform of mucin 1 (TnMUC1) chimeric antigen receptor T-cell (CAR-T) therapy in patients with TnMUC1-positive advanced cancers.

• Tmunity to Present at the 38th Annual J.P. Morgan Healthcare Conference

  1/9/2020

  Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 1:30 pm Pacific Time at the Westin St. Francis Hotel in San Francisco.

• Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients

  11/4/2019

  Tmunity will use Oncora Medical’s proprietary analytical tools to access real world data and innovate clinical trial design

• Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies

  10/31/2019

  Series B investors include venture capital, industry, academia, patient advocacy groups and philanthropy

• Tmunity Announces Exclusive License and Research Collaboration with Children’s Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma

  10/1/2019

  Tmunity Therapeutics, Inc. announced it has entered into an exclusive license and research collaboration agreement with Children’s Hospital of Philadelphia to advance a glypican 2 chimeric antigen receptor T-cell therapy for the treatment of neuroblastoma, a rare cancer that affects the developing nervous system.

• Tmunity Announces Presentation at the Cantor Fitzgerald 2019 Global Healthcare Conference

  9/27/2019

  Tmunity Therapeutics, Inc. announced that Christina Coughlin, MD, PhD, Executive Vice President and Chief Medical Officer, and members of the management team plan to participate at the Cantor Fitzgerald 2019 Global Healthcare Conference in New York City on October 3, 2019.

• Tmunity Announces Participation at Upcoming Investor Conferences

  8/23/2019

  Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at two investor conferences in September and October 2019.

• Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

  7/9/2019

  Partnership will accelerate access to novel therapeutics for patients with devastating diseases

• Tmunity Announces June 2019 Investor Conference Schedule

  5/23/2019

  Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at an investor conference in June 2019.

• Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers

  5/1/2019

  Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor

• 

  First U.S. Patients Are Treated With CRISPR as Echoes of Scandal in China Still Linger

  4/17/2019

  The first clinical trials using CRISPR technology are expected to get underway in the United States, even as echoes of a scandal involving the use of CRISPR on embryos in China are still being felt across the globe.

• Tmunity Announces Participation at Four Upcoming Investor Conferences

  3/1/2019

  Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at four investor conferences in March 2019.

• Tmunity Appoints Patrick Gray and Garry Nicholson to its Board of Directors as Independent Directors

  2/14/2019

  Tmunity Therapeutics is a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy

• Tmunity to Present at the 37th Annual J.P. Morgan Healthcare Conference

  12/21/2018

  Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference

• 

  19 (at Least!) of TIME Magazine’s 50 Most Influential Healthcare People Have Biopharma Ties

  10/19/2018

  TIME Magazine came out with a list of the 50 most influential people in healthcare, dubbed The Health Care 50. A look through the list shows just how many ties and connections—as well as influence—this group has on the biopharma industry.